Navigation Links
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
Date:2/6/2009

except per share) Three Months Ended Twelve Months Ended December 31, December 31, 2008 2007 2008 2007 Revenues: Collaborative and other research and development $34,240 $28,172 $56,561 $71,238 Expenses: Research and development 22,060 29,114 73,327 94,052 General and administrative 2,376 2,486 10,399 9,466 Total expenses 24,436 31,600 83,726 103,518 Income (loss) from operations 9,804 (3,428) (27,165) (32,280) Interest and other income 266 1,145 2,433 3,225 Net income (loss) $10,070 $(2,283) $(24,732) $(29,055) Basic and diluted net income (loss) per common share $0.26 $(0.06) $(0.65) $(0.89) Basic weighted average shares outstanding 38,126 37,954 38,062 32,771 Diluted weighted average shares outstanding 38,355 37,954 38,062 32,771 Balance Sheet Data (in thousands) December 31, 2008 December 31, 2007 (Unaudited) (Note 1) Cash, cash equivalents and securities $63,314 $85,008 Receivables from collaborations 11,982 39,128 Total assets 84,692 142,717 Accumulated deficit (249,268) (224,536) Stockholders' equity 46,426 64,905 Note 1: Derived from audited financial statements.


'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
2. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
3. BioCryst to Present at UBS 2007 Global Life Sciences Conference
4. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
6. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
7. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
8. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. BioCryst to Present at UBS 2008 Global Life Sciences Conference
11. BioCryst to Present at the JMP Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 18, 2014 Reports from ... United States suffer from one or more chronic health ... cancer. Medication can address some of these diseases, but ... that many sufferers face. While implanted nerve stimulation devices ... the whole nerve, which can induce side effects. ...
(Date:12/19/2014)... With only 2 weeks left of ... Sartorius Biohit products . The product specials include Buy ... Pipette Trade-in Program, and free pipette tips. , Sartorius ... the world. They are ideal for lab technicians performing ... ,     Full volume range of 0.1 uL to ...
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... Houston, TX (PRWEB) December 17, 2014 ... marketing and administration for Stoller Group. In this position, ... Stoller Group, on administrative matters, develop marketing strategy and ... and services. , “Achim has tremendous knowledge and ... president of Stoller Group. “His experience and innovative thinking ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... Annual ... Scientific Session -, FREMONT, Calif., April ... company, presented data from a,study providing further confirmation that the Company,s ... The research suggests that such a panel may be useful in ...
... HUBBARD, Ohio, April 8, 2008 NanoLogix, Inc.,(OTC ... 2007 financial data and a director appointment., ... were,reduced by 42% over 2006, while funding for ... information can be accessed at:, http://www.nanologixinc.com/financials.html , ...
... Report,Transfer Across Disparate PACS and Maintains Hospital Group,s Operations as ... ... Crashes, SEATTLE, April 8, 2008 Compressus, leaders in,interoperability ... integrated digital imaging and data management,solution at E-Rad Solutions teleradiology ...
Cached Biology Technology:Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease 2Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease 3NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director 2Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers 2Compressus Completes Interoperability Implementation for E-Rad Solutions Teleradiology Customers 3
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
(Date:12/3/2014)... GLENDALE, Ariz. , Dec. 2, 2014 ... biometric hand readers, Inception Technologies is pleased to announce ... it easier for customers to collect the workforce data ... the problems that have been left by existing readers. ... to user interface, connectivity and modern technology. Older models ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2
... from NOAA and Texas A&M UniversityCorpus Christi were astounded to ... as some of the most common ocean habitats in the ... reverse previous beliefs about the prevalence of seamounts, which are ... coral reefs, most people will never see a seamount, but ...
... Governor Charlie Crist declared a state of emergency in ... for Southeastern Tropical Advanced Remote Sensing (CSTARS) at the ... international satellite data providers to acquire critical environmental imagery ... platform caught fire after an explosion on April 20 ...
... plants and science, nurtured by early days spent on her ... in the study of plants - and now to a ... work at Kansas State University. The five-year award will ... at K-State, to study how insects that serve as vectors ...
Cached Biology News:Scientists identify seamounts as significant, unexplored territory 2K-State scientist to receive $1 million CAREER award 2K-State scientist to receive $1 million CAREER award 3
CKB Antibody (N-term) Antigen: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected within aa 1~100 of human CKB. Molecular Weight: 42644 Da...
Anti-Digoxigenin-AP, Fab fragments; from sheep...
2 ml SmartScan Racks...
Request Info...
Biology Products: